Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

CB1 cannabinoid receptor activation involved in cirrhosis-associated hypotension

Nov. 21, 2000

United Therapeutics and Antigen sign distribution agreement for UT-15

Nov. 21, 2000

Reverse Na+/Ca2+ exchange inhibitor KB-R7943 studied in arrhythmia, reperfusion

Nov. 21, 2000

MCI-154 shown to increase myofilament cooperativity

Nov. 20, 2000

ET-1 antisense ODNs show antiarrhythmic effects in AMI

Nov. 20, 2000

Y-27632 explored as vasodilator for HF

Nov. 20, 2000

Early clinical data support further development of sitaxsentan for PAH

Nov. 17, 2000

AHA news: preclinical studies support use of PD-180988 for the management of pulmonary hypertension

Nov. 17, 2000

LU-135252 produces hemodynamic and neurohumoral benefits in advanced heart failure

Nov. 17, 2000

SB's new ET receptor antagonists covered by U.S. patent

Nov. 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...